A company that is ready for an FDA inspection is less likely to receive 483 observations than a disorganized one. This 60-minute webinar covers how to prepare for and host an FDA inspection, and what to do if a Form 483 or warning letter follows.
You'll look at the types of FDA inspections, assigning people to specific inspection tasks, setting up front room and back room facilities, the value of mock audits, and how staff should behave, including what not to sign.
The session also explains the FDA's rights during an inspection, the documents you are not required to show, and why the timing and content of your 483 response matter so much.
The FDA will inspect you, so the question is whether you're ready. Preparation lowers the chance of 483s, and knowing how to respond to a 483 reduces the chance it turns into a warning letter.
The webinar suits medical device companies marketing in the U.S. and their executives, regulatory, QA, quality and compliance managers, auditors, quality engineers, CAPA specialists, management representatives, consultants and anyone who may deal directly with FDA officials.
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, fields. The employees who will benefit include:
The FDA will inspect you, so the question is whether you're ready. Preparation lowers the chance of 483s, and knowing how to respond to a 483 reduces the chance it turns into a warning letter.
The webinar suits medical device companies marketing in the U.S. and their executives, regulatory, QA, quality and compliance managers, auditors, quality engineers, CAPA specialists, management representatives, consultants and anyone who may deal directly with FDA officials.
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, fields. The employees who will benefit include:
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
New Form I-9: Documents and Policies that Ensure ICE I-9 Co…
Claude AI For CPAs & Finance Professionals: Best Practices …
Secrets Of Psychology - Why People Do The Things They Do
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Project Management For Administrative Professionals
Onboarding is NOT Orientation - How to Improve the New Empl…
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
Managing Complex Projects - Project Management
Utilizing HR Metrics to Illustrate & Improve Human Resource…
Negotiating Skills For Professional Results - Winning Strat…
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
Paying and Receiving Payments for Referrals: You Can Go to …
FDA Technology Modernization Action Plan (TMAP) and Impact …
Human Factors Usability Studies Following ISO 62366 and FDA…
Construction Lending And Real Credit Administration: Evalua…
Validation Statistics for Non-Statisticians
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …
Batch Record Review and Product Release
Discover how Emotional Intelligence turns AI from a technic…
Copilot and HR: An Introduction for HR Professionals
ChatGPT for HR - Build HR Policy Framework and Strategy
Female to Female Hostility @Workplace: All you Need to Know